Skip to main content

Market Overview

Morning Market Movers


Chembio Diagnostics (NASDAQ: CEMI) gained 21.56% to $4.85 after the company reported that it has partnered with Integrated BioTherapeutics to develop point-of-care diagnostic tests for Ebola and Febrile Illness.

Alexza Pharmaceuticals (NASDAQ: ALXA) shares surged 16.70% to $2.65. Ferrer purchased $8 million of Alexza common stock through new investment and elimination of potential milestone payments.

NQ Mobile (NYSE: NQ) shares jumped 14.21% to $10.21 after the company filed its SEC Form 20-F,l which showed full compliance and no attempts to delete documents.

Digital Power (NYSE: DPW) shares gained 11.89% to $2.07 after the company reported that it has been awarded an additional $1.6 million defense export order.

Prosensa Holding N.V. (NASDAQ: RNA) shares climbed 11.66% to $13.41 on the FDA requirement of additional data from Sarepta on Eteplirsen.

Vanda Pharmaceuticals (NASDAQ: VNDA) shares surged 9.27% to $12.14 on Q3 results. Vanda Pharma posted a quarterly loss of $0.64 per share on revenue of $10.90 million.

Novavax (NASDAQ: NVAX) shares surged 6.35% to $5.46 after the company announced Ebola vaccine development program at the 8th Vaccine And ISV Conference in Philadelphia.

CorMedix (NYSE: CRMD) shares gained 4.25% to $1.89 after the company received an approval from the FDA to initiate a clinical trial for Neutrolin in the US.

Micron Technology (NASDAQ: MU) rose 3.04% to $32.01 after the company announced a new $1 billion stock repurchase authorization.


Related Articles (ALXA + CEMI)

View Comments and Join the Discussion!

Posted-In: market moversNews Intraday Update Markets Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at